Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy: Phase I Study of Feasibility and Safety

NCT01649648 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT01649648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01649648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy: Phase I Study of Feasibility and Safety
Lead sponsor
National University Hospital, Singapore
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2011
Completion date
November 30, 2015
Enrollment
2 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic ischemic encephalopathy